NCT06496893View on ClinicalTrials.gov

A Study to Assess Effect of Glucocil® on Metabolic Health in Individuals With Prediabetes and Type 2 Diabetes Mellitus.

NANot yet recruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

July 25, 2024

Primary Completion Date

December 25, 2024

Study Completion Date

December 30, 2024

Conditions

Pre DiabetesType2 Diabetes Mellitus

Interventions

DIETARY_SUPPLEMENT

IP 1200 mg per soft gel capsule

Two soft gels to be taken with breakfast and two soft gels to be taken with dinner

DIETARY_SUPPLEMENT

Placebo Comparator: Placebo 1200 mg per soft gel capsule

Two soft gels to be taken with breakfast and two soft gels to be taken with dinner

Trial Locations (5)

221001

Upendra Medicare, Varanasi

221011

Arihant Hospital, Varanasi

302033

Dr.Govinds Clinic,, Jaipur

421503

Shri balaji Multispeciality hospital,, Thāne

Unknown

Shourya clinic, Pune

All Listed Sponsors

lead

Vedic Lifesciences Pvt. Ltd.

INDUSTRY

NCT06496893 - A Study to Assess Effect of Glucocil® on Metabolic Health in Individuals With Prediabetes and Type 2 Diabetes Mellitus. | Biotech Hunter | Biotech Hunter